• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受肠肝循环影响的甾体药物药代动力学模型系统。

Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.

作者信息

Schumann W, Hillesheim H G, Gira G

出版信息

Exp Clin Endocrinol. 1986 Jul;87(2):118-24. doi: 10.1055/s-0029-1210532.

DOI:10.1055/s-0029-1210532
PMID:3758191
Abstract

A number of drugs including steroid hormones undergo enterohepatic circulation (EHC) which influences the drug disposition parameters. EHC of drugs leads to prolonged drug exposition which may enhance the risk of liver incompatibility. The extent of EHC expressed by the reabsorption rate of a given drug is of interest from the clinical and toxicological point of view. A two-compartment model with an additional time lag was realized by a hybrid computer system to study the influence of EHC on the shape of plasma concentration-time profiles and pharmacokinetic parameters. Reabsorption rates of potential steroid drugs were calculated by model-simulation and the results compared with the experimentally found ones. Although the lag time model is only a simplified approximation to the underlying physiological processes it reflects sufficiently the pharmacokinetic profile of steroid drugs subject to EHC.

摘要

包括甾体激素在内的多种药物会经历肠肝循环(EHC),这会影响药物处置参数。药物的肠肝循环会导致药物暴露时间延长,这可能会增加肝脏不相容性的风险。从临床和毒理学角度来看,用特定药物的重吸收率表示的肠肝循环程度是令人感兴趣的。通过混合计算机系统实现了一个具有额外时间滞后的二室模型,以研究肠肝循环对血药浓度-时间曲线形状和药代动力学参数的影响。通过模型模拟计算了潜在甾体药物的重吸收率,并将结果与实验结果进行了比较。尽管滞后时间模型只是对潜在生理过程的一种简化近似,但它充分反映了受肠肝循环影响的甾体药物的药代动力学特征。

相似文献

1
Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.受肠肝循环影响的甾体药物药代动力学模型系统。
Exp Clin Endocrinol. 1986 Jul;87(2):118-24. doi: 10.1055/s-0029-1210532.
2
Drug control of steroid metabolism by the hepatic endoplasmic reticulum.肝脏内质网对类固醇代谢的药物控制。
Drug Metab Rev. 1983;14(6):1119-44. doi: 10.3109/03602538308991424.
3
A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.一种用于分析经历肠肝循环的药物处置曲线的药代动力学模型。
J Pharm Pharmacol. 2002 Jul;54(7):929-34. doi: 10.1211/002235702760089045.
4
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.双氯芬酸和罗非昔布在大鼠体内肠肝循环的群体药代动力学建模
Br J Pharmacol. 2008 Mar;153(5):1072-84. doi: 10.1038/sj.bjp.0707643. Epub 2008 Jan 14.
5
A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.药物及其共轭代谢物对肝肠循环的可逆清除模型。
Drug Metab Dispos. 1990 Jan-Feb;18(1):80-7.
6
Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.具有肠肝循环和再代谢的17室药代动力学模型中的渐近性和生物利用度。
Math Biosci. 2006 Sep;203(1):19-36. doi: 10.1016/j.mbs.2006.02.001. Epub 2006 Apr 17.
7
Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings.用于解释吡罗昔康在人体内肝肠循环机制的生理驱动时滞模型。
Basic Clin Pharmacol Toxicol. 2009 Jan;104(1):35-42. doi: 10.1111/j.1742-7843.2008.00304.x.
8
Role of enterohepatic recirculation in drug disposition: cooperation and complications.肠肝循环在药物处置中的作用:合作与并发症。
Drug Metab Rev. 2016 May;48(2):281-327. doi: 10.3109/03602532.2016.1157600. Epub 2016 Mar 18.
9
A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.一种用于大鼠双氯芬酸肠肝循环处置动力学的新分析方法。
Drug Metab Dispos. 1994 May-Jun;22(3):479-85.
10
Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.恒河猴肠肝循环的群体药代动力学建模
Eur J Pharm Sci. 2005 Oct;26(2):151-61. doi: 10.1016/j.ejps.2005.05.010.